Evidence map›Paper›PMID 28759037›Full record

ArticleOncogene2017

Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis.

J H Lee, Y-S Han, Y M Yoon, C W Yun, S P Yun, S M Kim, H Y Kwon, D Jeong, M J Baek, H J Lee and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. PrPInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The Cellular Prion Protein: A Promising Therapeutic Target for Cancer.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

J H LeeDepartment of Pharmacology and Toxicology, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
Y-S HanMedical Science Research Institute, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
Y M YoonMedical Science Research Institute, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
C W YunMedical Science Research Institute, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
S P YunNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
S M KimNeuroregeneration and Stem Cell Programs, Institute for Cell Engineering Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
H Y KwonSoonchunhyang Institute of Medi-bio Science, Soonchunhyang University, Cheonan, Republic of Korea.
D JeongDepartment of Pathology, Collage of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.
M J BaekDepartment of Surgery, Collage of Medicine, Soonchunhyang University, Cheonan, Republic of Korea.
H J LeeDepartment of Veterinary Physiology, College of Veterinary Medicine and Research Institute for Veterinary Science, and BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Republic of Korea.
S-J LeeDepartment of Veterinary Physiology, College of Veterinary Medicine and Research Institute for Veterinary Science, and BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Republic of Korea.
H J HanDepartment of Veterinary Physiology, College of Veterinary Medicine and Research Institute for Veterinary Science, and BK21 PLUS Creative Veterinary Research Center, Seoul National University, Seoul, Republic of Korea.
S H LeeMedical Science Research Institute, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
Seoul National University · KRSoonchunhyang University · KRJohns Hopkins University · USSoonchunhyang University Hospital · KRUniversity of Alabama at Birmingham · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular prion protein (PrP

Indexed as

CarcinogenesisCell Culture TechniquesColorectal NeoplasmsDisease ProgressionFlow CytometryGene Knockdown TechniquesHSP70 Heat-Shock ProteinsHT29 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitMolecular Targeted TherapyPrion ProteinsProteasome Endopeptidase ComplexProteolysisReceptors, Autocrine Motility FactorRNA InterferenceAMFR protein, humanHIF1A protein, humanHSP70 Heat-Shock ProteinsHSPA1L protein, humanHypoxia-Inducible Factor 1, alpha SubunitPrion ProteinsProteasome Endopeptidase ComplexReceptors, Autocrine Motility FactorRNA, Small Interfering

Identifiers

PMID28759037
OpenAlexW2741262361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.